Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung Cancer

BACKGROUND: There is an urgent need for a companion assay to work with mesothelin-targeted therapeutic agents and for noninvasive and accurate prognostication of malignant mesothelioma (MM) patients. We report the development and validation of a blood-based assay for megakaryocyte potentiating facto...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Appl Lab Med
Hoofdauteurs: Yu, Yunkai, Ryan, Bríd M., Thomas, Anish, Morrow, Betsy, Zhang, Jingli, Kang, Zhigang, Zingone, Adriana, Onda, Masanori, Hassan, Raffit, Pastan, Ira, Cao, Liang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201267/
https://ncbi.nlm.nih.gov/pubmed/30370398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/jalm.2017.025015
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items